These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21049296)

  • 41. Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis?
    Field LD; Delehanty JB; Chen Y; Medintz IL
    Acc Chem Res; 2015 May; 48(5):1380-90. PubMed ID: 25853734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chapter 14 - Synthesis, characterization, and optical response of gold nanoshells used to trigger release from liposomes.
    Wu G; Mikhailovsky A; Khant HA; Zasadzinski JA
    Methods Enzymol; 2009; 464():279-307. PubMed ID: 19903560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanoparticles in drug delivery.
    Douglas SJ; Davis SS; Illum L
    Crit Rev Ther Drug Carrier Syst; 1987; 3(3):233-61. PubMed ID: 3549008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applications of nanodiamonds in drug delivery and catalysis.
    Moosa B; Fhayli K; Li S; Julfakyan K; Ezzeddine A; Khashab NM
    J Nanosci Nanotechnol; 2014 Jan; 14(1):332-43. PubMed ID: 24730266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design strategies of hybrid metallic nanoparticles for theragnostic applications.
    Gautier J; Allard-Vannier E; Hervé-Aubert K; Soucé M; Chourpa I
    Nanotechnology; 2013 Nov; 24(43):432002. PubMed ID: 24107712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surface engineering of inorganic nanoparticles for imaging and therapy.
    Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
    Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heat profiling of three-dimensionally optically trapped gold nanoparticles using vesicle cargo release.
    Kyrsting A; Bendix PM; Stamou DG; Oddershede LB
    Nano Lett; 2011 Feb; 11(2):888-92. PubMed ID: 21188965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of nanocapsules for colon-targeted drug delivery system.
    Kshirsagar SJ; Bhalekar MR; Patel JN; Mohapatra SK; Shewale NS
    Pharm Dev Technol; 2012; 17(5):607-13. PubMed ID: 21428704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PLGA/polymeric liposome for targeted drug and gene co-delivery.
    Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
    Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functionalization of liposomes: microscopical methods for preformulative screening.
    Belletti D; Vandelli MA; Tonelli M; Zapparoli M; Forni F; Tosi G; Ruozi B
    J Liposome Res; 2015; 25(2):150-6. PubMed ID: 25203607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localized functionalization of individual colloidal carriers for cell targeting and imaging.
    Yake AM; Zahr AS; Jerri HA; Pishko MV; Velegol D
    Biomacromolecules; 2007 Jun; 8(6):1958-65. PubMed ID: 17477569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles.
    Ergen C; Heymann F; Al Rawashdeh W; Gremse F; Bartneck M; Panzer U; Pola R; Pechar M; Storm G; Mohr N; Barz M; Zentel R; Kiessling F; Trautwein C; Lammers T; Tacke F
    Biomaterials; 2017 Jan; 114():106-120. PubMed ID: 27855336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Principles of nanoparticle design for overcoming biological barriers to drug delivery.
    Blanco E; Shen H; Ferrari M
    Nat Biotechnol; 2015 Sep; 33(9):941-51. PubMed ID: 26348965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endocytosis in cellular uptake of drug delivery vectors: Molecular aspects in drug development.
    Kaźmierczak Z; Szostak-Paluch K; Przybyło M; Langner M; Witkiewicz W; Jędruchniewicz N; Dąbrowska K
    Bioorg Med Chem; 2020 Sep; 28(18):115556. PubMed ID: 32828419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
    Bhateria M; Rachumallu R; Singh R; Bhatta RS
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.